Concerns regarding vaccinations continue to increase exponentially in light of all of the information and documentation that has surfaced over the past few years. As a result, corporate media has responded to alternative media, stating that the increase of persons who are choosing to opt out of vaccines and the recommended vaccine schedule is a result of ‘fear mongering.’
This may not be too surprising as the corporate media is owned by the major vaccine manufacturers, and the major vaccine manufacturers are owned by corporate media(1)(2)(3)(4). Given this fact, it’s easy to fathom the possibility that these institutions are desperately trying to protect the reputation of their product.
For example, if we take a look at GlaxoSmithKline and Pfizer, they are owned by the same financial institutions and groups that own Time Warner (CNN, HBO etc.) and General Electric (NBC, Comcast, Universal Pictures etc.).(1)(2)(3)(4) This is seen throughout all of the major vaccine manufacturers and all of the 6 corporations that control our mainstream media. Keep in mind that these are the major funders of all ‘medical research’ that’s used to administer drugs and vaccinations. Despite these connections, medical research and documentation exists to show that vaccines might indeed be a cause for concern.
This really should be one of the biggest public health scandals of the decade, but instead it’s given little attention – mainly because of the high-profile nature of the people and organisations involved.
The United Nations has been forced to admit that a major international vaccine initiative is actually causing a deadly outbreak of the very disease it was supposed to wipe-out.
While international organisations like the World Health Organization (WHO) will regularly boast about ‘eradicating polio’ with vaccines—the opposite seems to be the case, with vaccines causing the deaths of scores of young people living in Africa.
Health officials have now admitted that their plan to stop ‘wild’ polio is backfiring, as scores children are being paralyzed by a deadly strain of the pathogen derived from a live vaccine – causing a virulent wave of polio to spread.
This latest pharma-induced pandemic started out in the African countries of Chad and Sudan, with the culprit identified as vaccine-derived polio virus type 2.
Officials now fear this new dangerous strain could soon ‘jump continents,’ causing further deadly outbreaks around the world.
Shocking as it sounds, this Big Pharma debacle is not new. After spending some $16 billion over 30 years to eradicate polio, international health bodies have ‘accidentally’ reintroduced the disease to in Pakistan, Afghanistan, and also Iran, as the central Asia region was hit by a virulent strain of polio spawned by the a pharmaceutical vaccine. Also, in 2019, the government of Ethiopia ordered the destruction of 57,000 vials of type 2 oral polio vaccine (mOPV2) following a similar outbreak of vaccine-induced polio.
The same incident has happened in India as well.
It’s important to note that the oral polio vaccine is being pushed by the Global Polio Eradication Initiative (GPEI), a consortium which is supported and funded by the Bill & Melinda Gates Foundation.
Few people know that new prescription drugs have a 1 in 5 chance of causing serious reactions after they have been approved. That is why expert physicians recommend not taking new drugs for at least five years unless patients have first tried better-established options, and have the need to do so.
Few know that systematic reviews of hospital charts found that even properly prescribed drugs (aside from misprescribing, overdosing, or self-prescribing) cause about 1.9 million hospitalizations a year. Another 840,000 hospitalized patients are given drugs that cause serious adverse reactions for a total of 2.74 million serious adverse drug reactions. About 128,000 people die from drugs prescribed to them. This makes prescription drugs a major health risk, ranking 4th with stroke as a leading cause of death. The European Commission estimates that adverse reactions from prescription drugs cause 200,000 deaths; so together, about 328,000 patients in the U.S. and Europe die from prescription drugs each year. The FDA does not acknowledge these facts and instead gathers a small fraction of the cases.
Perhaps this is “the price of progress”? For example, about 170 million Americans take a prescription drug, and many benefit from the drug. For some, drugs save their life or keep them alive. About 80 percent of them are generic; that is to say, drugs whose benefits and risks are better known. If we suppose they all benefit, then 2.7 million severe reactions is only about 1.5 percent.
But as far as we can tell (very little research is funded on prescription drugs as a health risk compared to less deadly risks like diabetes or Alzheimer’s disease), millions who take new, patented drugs experience only modest benefits over established drugs. Only a small percent of new drugs provide significant advantages for patients to offset these risks of harm. Independent reviews over the past 35 years have found that only 11 to 15 percent of newly approved drugs have significant clinical advantages over existing, better-known drugs. These contribute to the large medicine chest of effective drugs developed over the decades. But the 85 to 89 percent with little or no clinical advantage flood the market. About four-fifths of the additional $70 billion spent on drugs since 2000 in the U.S. (and another $70 billion abroad) have been spent on these minor new variations rather than on the really innovative drugs.